Dementia Alzheimer's type
RecruitingStudy of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease
Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease
- Disease:Dementia Alzheimer's type
- Substances:Trospium ChlorideXanomeline Tartrate
Poland- Participants:18–64 years · 65+ years
- Substances:Trospium Chloride
- Sponsor:Bristol-Myers Squibb Services Unlimited Company













